Medical Properties Trust, Inc. (NYSE:MPW – Get Free Report) Director C Reynolds Thompson III sold 20,530 shares of the firm’s stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total transaction of $89,921.40. Following the transaction, the director now owns 54,637 shares of the company’s stock, valued at approximately $239,310.06. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Medical Properties Trust Price Performance
Medical Properties Trust stock opened at $4.43 on Wednesday. The business’s 50 day simple moving average is $4.65 and its 200 day simple moving average is $4.59. Medical Properties Trust, Inc. has a 12 month low of $2.92 and a 12 month high of $7.40. The company has a market cap of $2.66 billion, a price-to-earnings ratio of -2.00, a PEG ratio of 0.65 and a beta of 1.27. The company has a current ratio of 3.10, a quick ratio of 3.10 and a debt-to-equity ratio of 1.51.
Medical Properties Trust (NYSE:MPW – Get Free Report) last issued its quarterly earnings results on Thursday, August 8th. The real estate investment trust reported ($0.54) EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.75). The firm had revenue of $266.60 million during the quarter, compared to analysts’ expectations of $259.53 million. Medical Properties Trust’s revenue was down 21.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.48 earnings per share. Sell-side analysts forecast that Medical Properties Trust, Inc. will post 0.88 EPS for the current year.
Medical Properties Trust Cuts Dividend
Analysts Set New Price Targets
MPW has been the topic of several recent analyst reports. StockNews.com cut Medical Properties Trust from a “hold” rating to a “sell” rating in a research note on Saturday, May 18th. Royal Bank of Canada restated a “sector perform” rating and set a $5.00 price target on shares of Medical Properties Trust in a report on Tuesday, May 14th. BNP Paribas cut shares of Medical Properties Trust from an “outperform” rating to a “neutral” rating and dropped their target price for the stock from $6.00 to $4.00 in a research report on Tuesday, July 2nd. Finally, Truist Financial upped their target price on Medical Properties Trust from $4.50 to $5.00 and gave the company a “hold” rating in a report on Thursday, May 30th. Three investment analysts have rated the stock with a sell rating and eight have issued a hold rating to the company. According to data from MarketBeat, Medical Properties Trust has a consensus rating of “Hold” and a consensus price target of $4.86.
Check Out Our Latest Stock Report on Medical Properties Trust
Institutional Trading of Medical Properties Trust
Several hedge funds and other institutional investors have recently modified their holdings of the business. KPP Advisory Services LLC grew its stake in Medical Properties Trust by 20.7% in the 2nd quarter. KPP Advisory Services LLC now owns 95,041 shares of the real estate investment trust’s stock valued at $410,000 after buying an additional 16,280 shares in the last quarter. Cetera Investment Advisers boosted its holdings in shares of Medical Properties Trust by 1.7% in the second quarter. Cetera Investment Advisers now owns 353,121 shares of the real estate investment trust’s stock worth $1,522,000 after acquiring an additional 5,874 shares during the period. Sunbelt Securities Inc. grew its position in shares of Medical Properties Trust by 5.5% in the second quarter. Sunbelt Securities Inc. now owns 406,237 shares of the real estate investment trust’s stock valued at $1,751,000 after purchasing an additional 21,092 shares in the last quarter. Creative Planning grew its position in shares of Medical Properties Trust by 42.6% in the second quarter. Creative Planning now owns 326,293 shares of the real estate investment trust’s stock valued at $1,406,000 after purchasing an additional 97,546 shares in the last quarter. Finally, Algert Global LLC raised its stake in shares of Medical Properties Trust by 91.5% during the 2nd quarter. Algert Global LLC now owns 183,881 shares of the real estate investment trust’s stock valued at $793,000 after purchasing an additional 87,881 shares during the period. Institutional investors own 71.79% of the company’s stock.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
See Also
- Five stocks we like better than Medical Properties Trust
- What is the Dow Jones Industrial Average (DJIA)?
- Study: How Much Are Retirees Earning from Side Hustles in 2024?
- Business Services Stocks Investing
- Brinker International Offers a Pullback Opportunity on EPS Miss
- Investing in the High PE Growth Stocks
- Globant Is an Emerging AI Play That’s Expanding Its Footprint
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.